Intelligence · Clinical Pipeline
Oncology R&D Pipeline
Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
- Programs
- 5,568
Quick answer
Oncology: NovaPharmaNews indexes 5,568 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Top sponsors
- First People's Hospital 474 programs
- Chinese Academy of 401 programs
- United Therapeutics Europe 219 programs
- George Institute for 174 programs
- Takeda 163 programs
- AstraZeneca 145 programs
- HOFFMANN-LA ROCHE 145 programs
- MSD Merck Sharp 131 programs
- Anaxis Pharma 129 programs
- Regeneron UK 128 programs
- Telethon Foundation 113 programs
- Novartis India 112 programs
-
Liquid Biopsy Early Screening
The First People's Hospital of Lianyungang
Liquid Biopsy for Early Screening of Lung Cancer
1 trial -
Lugol's Solution (1.5%)
Hospital Authority, Hong Kong
Esophageal Squamous Cell Neoplasm
1 trial -
MR/PET
Hospital Authority, Hong Kong
Non-small Cell Lung Cancer
1 trial -
MTBF regimen
The First People's Hospital of Lianyungang
Relapse Leukemia
1 trial -
MV-PRS Sub-study
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Metformin
The First People's Hospital of Lianyungang
Endometrial Cancer
1 trial -
Metoclopramide 10mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Cancer
1 trial -
Mitoxantrone hydrochloride liposome injection
The First People's Hospital of Lianyungang
Diffuse Large B-cell Lymphoma
1 trial -
Mitoxantrone hydrochloride liposome injection30mg/m2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Myeloid Leukemia
1 trial -
Nab-paclitaxel
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
Next generation sequencing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastrointestinal Cancer
1 trial -
Nicotine Replacement
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking-Related Carcinoma
2 trials -
Nutrition Intervention
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
Nutritional therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cancer
1 trial -
Obinutuzumab
The First People's Hospital of Lianyungang
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
1 trial -
PEG-rhG-CSF
The First People's Hospital of Lianyungang
Lymphoma
1 trial -
POHIM-RT
Samsung Bioepis NL B.V.
Cervix Cancer
1 trial -
PSMA PET/CT
The First People's Hospital of Lianyungang
Prostate Adenocarcinoma
1 trial -
PSMA PET/MRI-TRUS guided prostate targeted combined saturation biopsy
The First People's Hospital of Lianyungang
Prostate Cancer Screening
1 trial -
Paclitaxel Oral Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-Small-Cell Lung Cancer
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Cancers
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
The First People's Hospital of Lianyungang
Breast Cancers
1 trial -
Paclitaxel, gemcitabine or liposomal doxorubicin with or without bevacizumab or biosimilar
The University of Hong Kong
Recurrent Ovarian Carcinoma
1 trial -
Peginterferon α-2b plus an anti-PD-1
The First People's Hospital of Lianyungang
Advanced Solid Tumors
1 trial -
Personalized Functional Profiling
Universal Integrated
Oncology
1 trial -
Personalized mRNA Tumor Vaccine
The First People's Hospital of Lianyungang
Esophageal Cancer
1 trial -
Pharmacogenomic Testing with the "Global Diversity Array with Enhanced PGx"
Atrium Therapeutics
Cancer
1 trial -
Postoperative radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Tongue Squamous Cell Carcinoma
1 trial -
Prediction Model Arm
The First People's Hospital of Lianyungang
Lung Cancer Screening
1 trial -
Preoperative three-dimensional reconstruction
Universal Integrated
Kidney Neoplasms / Surgery
1 trial -
Propofol
Hospital Authority, Hong Kong
Renal Cell Carcinoma
1 trial -
Prostate biopsy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
R-CDOP
The First People's Hospital of Lianyungang
Diffuse Large B Cell Lymphoma
1 trial -
RNAseq
Takeda
Non-small Cell Lung Cancer
1 trial -
Radiation
Adaptive Biotechnologies Corp
Rectal Cancer
1 trial -
Radiation therapy
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Radiotherapy combined with TKI and Anti-PD-1 Antibody
Jian Li
Stage IIIA Hepatocellular Carcinoma
1 trial -
Raman spectrum
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Reduction CTVp1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Regorafenib and Sintilimab in combination with electroacupuncture
The First People's Hospital of Lianyungang
Colorectal Cancer Metastatic
1 trial -
Rituximab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Peripheral T-Cell Lymphoma, Not Otherwise Specified
1 trial -
Rituximab, Methotrexate, and Thiotepa (R-MT) Induction Followed by Etoposide and Cytarabine (EA) Consolidation
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
Ropivacaine Hydrochloride 10 MG/ML [Naropin]
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial -
SPECT/CT imaging with 99mTc-P137 nuclide probe
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Sheng-Yu-Tang
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Leukemia
1 trial -
Short course palliative radiation.
Hospital Authority, Hong Kong
Cervical Cancer
1 trial -
Surgery combined with Target-reduction intensity-modulated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Surgery-radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
1 trial
Frequently asked questions
How many oncology pipeline programs are tracked?
5,568 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.
Data attribution: Data sources · All pipeline programs